Evidence map›Paper›PMID 40593707›Full record

ArticleNature communications2025

Low-temperature sequential deposition for efficient inverted perovskite solar cells.

Mengjiong Chen, Zhenzhen Qin, Ziyang Zhang, Wenxiang Xiang, Yingming Liu, Chuang Tian, Siyuan Chen, Yanbo Wang, Liyuan Han

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mengjiong ChenState Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai, China.
Zhenzhen QinState Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai, China.
Ziyang ZhangState Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai, China.
Wenxiang XiangState Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai, China.
Yingming LiuState Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai, China.
Chuang TianState Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai, China.
Siyuan ChenState Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai, China.
Yanbo WangState Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai, China. sjtu-wyb@sjtu.edu.cn.ORCID http://orcid.org/0000-0002-6061-7577
Liyuan HanState Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai, China. han.liyuan@sjtu.edu.cn.ORCID http://orcid.org/0000-0001-9766-9015

Funding

National Natural Science Foundation of China (National Science Foundation of China) U21A20171
6 · The paper itself

Abstract

Inverted perovskite solar cell has made significant progress in recent years. Although two-step sequential deposition shows the benefits to obtain higher quality large-size perovskite crystals, the high annealing temperature, which is required to achieve phase transition, leads to the desorption of self-assembled molecules at the buried interface and induces redundant lead iodide at the top interface. Here, we propose a low temperature sequential deposition method by introduce a tailor-made 3-ethyl-1-methyl-1H-imidazol-3-ium dimethyl phosphate into lead iodide precursor solution to facilitate the sufficient reaction between lead iodide and organic salts, and lower the energy barrier from delta- to alpha-perovskite. As a result, highly crystallized and pure alpha-phase perovskite films with large grain size are fabricated, preventing the damage to buried self-assembled molecules and the formation of redundant lead iodide, which contributes to a high open circuit voltage of 1.21 V and a certified efficiency of 26.0%. The encapsulated devices show improved stability following ISOS-D-3 and ISOS-L-2 protocols.

Identifiers

PMID40593707
PMCPMC12214784

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.